Literature DB >> 23402447

Demand-side policies to encourage the use of generic medicines: an overview.

Pieter Dylst1, Arnold Vulto, Steven Simoens.   

Abstract

Demand-side policies to encourage the use of generic medicines are important to increase their use. A plethora of different demand-side policies has already been initiated by European governments, thereby targeting physicians, pharmacists and patients. This review aims to give an overview of the different demand-side policies which governments have at their disposal and to evaluate their impact on the use of generic medicines. Positive knowledge and perceptions of physicians, pharmacists and patients of generic medicines are necessary prerequisites to increase the use of generic medicines and governments should initiate policies to achieve this. These policies should be combined with policies to increase their financial responsibility to the healthcare system and policies to facilitate the prescribing of generic medicines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23402447     DOI: 10.1586/erp.12.83

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  19 in total

1.  Does substitution of brand name medications by generics differ between pharmacotherapeutic classes? A population-based cohort study in France.

Authors:  Alicia Molinier; Aurore Palmaro; Vanessa Rousseau; Agnès Sommet; Robert Bourrel; Jean-Louis Montastruc; Haleh Bagheri
Journal:  Eur J Clin Pharmacol       Date:  2016-12-29       Impact factor: 2.953

2.  Patients' knowledge and attitude towards therapeutic reference pricing system in Slovenia.

Authors:  Nika Marđetko; Mitja Kos
Journal:  Int J Clin Pharm       Date:  2016-08-08

3.  Associations between generic substitution and patients' attitudes, beliefs and experiences.

Authors:  Jette Rathe; Pia Larsen; Morten Andersen; Maja Paulsen; Dorte Jarbøl; Janus Thomsen; Jens Soendergaard
Journal:  Eur J Clin Pharmacol       Date:  2013-06-14       Impact factor: 2.953

4.  Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform.

Authors:  Olivier J Wouters; Panos G Kanavos
Journal:  Bull World Health Organ       Date:  2015-06-18       Impact factor: 9.408

5.  Effects of drug price reduction and prescribing restrictions on expenditures and utilisation of antihypertensive drugs in Korea.

Authors:  Ki-Bong Yoo; Sang Gyu Lee; Sohee Park; Tae Hyun Kim; Jeonghoon Ahn; Mee-Hyun Cho; Eun-Cheol Park
Journal:  BMJ Open       Date:  2015-07-15       Impact factor: 2.692

6.  Patients' beliefs about generic medicines in Malaysia.

Authors:  Zhi Y Wong; Mohamed A Hassali; Alian A Alrasheedy; Fahad Saleem; Abdul H Yahaya; Hisham Aljadhey
Journal:  Pharm Pract (Granada)       Date:  2014-03-15

7.  Generic switching and non-persistence among medicine users: a combined population-based questionnaire and register study.

Authors:  Jette Rathe; Morten Andersen; Dorte Ejg Jarbøl; René dePont Christensen; Jesper Hallas; Jens Søndergaard
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

8.  Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications.

Authors:  Hye-Young Kwon; Brian Godman
Journal:  BMC Health Serv Res       Date:  2016-04-14       Impact factor: 2.655

9.  Prescribing Generic Medication in Chronic Musculoskeletal Pain Patients: An Issue of Representations, Trust, and Experience in a Swiss Cohort.

Authors:  Valérie Piguet; Stéphanie D'Incau; Marie Besson; Jules Desmeules; Christine Cedraschi
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

10.  Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland.

Authors:  A O'Leary; C Usher; M Lynch; M Hall; L Hemeryk; S Spillane; P Gallagher; M Barry
Journal:  BMC Res Notes       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.